Your patients need Leflunomide — here's how to help them get it

As a provider managing patients with rheumatoid arthritis, you know that continuity of DMARD therapy is essential for maintaining disease control and preventing joint damage. When patients call to report they can't fill their Leflunomide prescription, it creates a clinical problem that requires a practical solution — not just a therapeutic one.

This guide provides actionable strategies your practice can implement to help patients navigate Leflunomide supply disruptions in 2026. From pharmacy coordination to real-time inventory tools, these approaches can reduce treatment interruptions and improve the patient experience.

Understanding the current supply landscape

Leflunomide (generic for Arava) has a current findability score of 72/100 — generally available but subject to intermittent disruptions. The supply situation in 2026 is characterized by:

• Periodic stock-outs at chain pharmacies, particularly for the 20 mg tablet
• Regional variability in availability
• Better availability at independent and specialty pharmacies with diversified wholesaler relationships
• No FDA-listed critical shortage, but consistent patient-reported access difficulties

For a detailed analysis of the supply drivers, see our companion article: Leflunomide shortage: What providers and prescribers need to know.

Strategy 1: Recommend Medfinder to patients and staff

Medfinder is a real-time pharmacy inventory tool that allows patients (and practice staff) to search for Leflunomide availability at nearby pharmacies. It eliminates the frustrating cycle of calling pharmacy after pharmacy.

How to integrate Medfinder into your workflow

• Patient handouts: Include Medfinder (medfinder.com) on printed or digital materials given to patients prescribed Leflunomide or other medications with known supply variability.
• Staff training: Train your front-desk and care coordination staff to use Medfinder when patients call reporting difficulty finding their medication. A quick search can identify in-stock pharmacies before the patient leaves the office or while on the phone.
• EHR integration: Consider adding a standard note or smartphrase in your EHR that includes Medfinder as a resource for patients on supply-constrained medications.
• Provider portal: Visit medfinder.com/providers for tools specifically designed for healthcare providers and practice staff.

Strategy 2: Build relationships with independent and specialty pharmacies

Large chain pharmacies operate centralized inventory systems that can be inflexible during supply disruptions. Independent pharmacies, by contrast, often have significant advantages:

• Multiple wholesaler accounts: Many independent pharmacies maintain relationships with 2-3 different distributors (e.g., McKesson, Cardinal Health, AmerisourceBergen, plus secondary wholesalers). When one distributor is out of Leflunomide, they can check others.
• Flexible ordering: Independent pharmacists can often make real-time ordering decisions without waiting for centralized approval processes.
• Specialty focus: Some independent pharmacies specialize in rheumatology or autoimmune medications and maintain larger DMARD inventories as a result.
• Direct communication: You can often speak directly with the pharmacist-owner, facilitating faster coordination on behalf of your patient.

Action steps

• Identify 2-3 independent or specialty pharmacies in your area that reliably stock DMARDs
• Establish a point of contact at each pharmacy for supply-related issues
• Maintain an updated list of these pharmacies to share with patients when chain pharmacies are out of stock
• Consider reaching out to compounding pharmacies as a backup option for specialized needs

Strategy 3: Proactive prescription management

Many Leflunomide access problems can be prevented with proactive prescription management:

Early refill authorization

Encourage patients to request refills 7-10 days before their supply runs out. This provides a buffer for the pharmacy to source the medication if it's not immediately on the shelf. Consider setting up your EHR to generate refill reminders at the appropriate interval.

90-day prescriptions

Where insurance allows, write prescriptions for 90-day supplies. This reduces the frequency of refill-related supply issues and is often available through mail-order pharmacy programs. Patients who refill monthly face 12 potential supply disruptions per year; 90-day fills reduce that to 4.

Multiple pharmacy options on the prescription

When sending prescriptions electronically, consider having a conversation with the patient about which pharmacy to use. If their usual chain pharmacy has had stock issues, proactively send the prescription to an independent pharmacy that's more likely to have supply.

Samples and bridge supplies

If your practice has access to Leflunomide samples (brand Arava), maintain a small supply for patients experiencing acute access issues. Even a 1-2 week bridge supply can prevent treatment interruptions while the patient locates a pharmacy with stock.

Strategy 4: Develop a supply disruption protocol for your practice

Rather than managing Leflunomide (and other DMARD) access issues on an ad-hoc basis, consider developing a standardized protocol:

Step 1: Patient reports inability to fill prescription

• Care coordinator checks Medfinder for nearby pharmacies with stock
• If found: directs patient to in-stock pharmacy, transfers prescription if needed
• If not found locally: proceeds to Step 2

Step 2: Expanded pharmacy search

• Contact preferred independent/specialty pharmacies on your practice's list
• Check mail-order pharmacy options through patient's insurance
• If found: coordinate prescription transfer
• If not found: proceeds to Step 3

Step 3: Clinical intervention

• Provider reviews patient chart and assesses urgency
• Options: provide samples as bridge, authorize temporary alternative DMARD, schedule follow-up to reassess
• Document supply-related treatment change in chart
• Set follow-up reminder to re-evaluate when Leflunomide becomes available

Step 4: Follow-up

• Check on patient within 1-2 weeks to confirm access issue resolved
• If patient was switched to alternative: monitor response and plan return to Leflunomide when supply stabilizes

Strategy 5: Educate patients on self-advocacy

Empowered patients are more successful at navigating supply disruptions. Provide patients with:

• A list of resources: Medfinder, independent pharmacy contacts, mail-order options
• Timing guidance: When to request refills, best days to call pharmacies (early in the week after deliveries)
• Escalation instructions: When to call your office (e.g., if they can't find the medication within 3 days, or if they have less than 1 week of supply remaining)
• Written materials: Share our patient-facing articles: How to find Leflunomide in stock and How to save money on Leflunomide

Clinical reminders for Leflunomide management

While managing supply-related issues, keep these clinical considerations in mind:

• Long half-life: Teriflunomide (active metabolite) has a 14-18 day half-life. Brief gaps (days to 1-2 weeks) are unlikely to cause acute loss of therapeutic effect, but this buffer should not justify complacency about access.
• Washout for transitions: If switching to Methotrexate, consider cholestyramine washout (8g TID × 11 days) or activated charcoal (50g BID × 11 days) to reduce hepatotoxicity risk from overlapping drug exposure.
• Monitoring continuity: Continue regular LFT and CBC monitoring regardless of supply disruptions. If treatment is interrupted and restarted, reassess baseline labs before resuming.
• Pregnancy planning: Leflunomide is Category X. Any supply disruption involving a patient of reproductive age should include a conversation about contraception and the washout procedure if pregnancy is being considered.

For drug interaction considerations, refer to our clinical guide on Leflunomide drug interactions.

Final thoughts

Supply disruptions for medications like Leflunomide are an increasingly common reality in clinical practice. By building systematic approaches — real-time inventory tools, pharmacy relationships, proactive prescription management, and clear patient communication — your practice can minimize the impact of these disruptions on patient care.

The strategies in this guide require modest upfront investment in coordination but pay significant dividends in patient satisfaction, treatment continuity, and reduced time spent on reactive problem-solving.

Visit medfinder.com/providers to explore how Medfinder can support your practice.

Related: Leflunomide shortage update for providers | Help patients save money on Leflunomide | Leflunomide alternatives